Seminar Dr. Suhong Kim [Merck & Co., Inc., USA] - Development of MK-7845 as an Investigational Treatment for Covid-19 Date 2024-11-20 14:22 Date: 2024/11/29 (FRI) 2PM Venue: Science Hall 429
